14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Nov 27, 2023 Buy 64 289 Scott John K Jr. Series J Convertible Preffered Stock
Nov 27, 2023 Sell 2 270 Scott John K Jr. Series G Redeemable Preferred Stock
Nov 27, 2023 Sell 2 400 Scott John K Jr. Series I Convertible Preferred Stock
Nov 16, 2023 Buy 416 667 Moss Dana J Common Stock
Nov 16, 2023 Buy 200 000 Moss Dana J Common Stock
Nov 16, 2023 Buy 416 667 Stefanelli Jill Common Stock
Nov 16, 2023 Buy 275 000 Stefanelli Jill Common Stock
Jul 28, 2023 Buy 0 Dais Craig
Jul 11, 2023 Buy 250 000 Moss Dana J Common Stock
Jul 11, 2023 Buy 0 Moss Dana J
Jun 29, 2023 Buy 12 200 000 Scott John K Jr. Common Stock
Jun 08, 2023 Buy 250 000 Stefanelli Jill Common Stock
Jun 05, 2023 Buy 11 508 672 Scott John K Jr. Common Stock
Jun 05, 2023 Sell 11 969 Scott John K Jr. Series J Convertible Preferred Stock
Jun 01, 2023 Buy 11 969 Scott John K Jr. Series J Convertible Preferred Stock
Jun 01, 2023 Sell 990 Scott John K Jr. Series G Redeemable Preferred Stock
Jun 01, 2023 Buy 0 Stefanelli Jill
Nov 30, 2022 Buy 1 250 Witter Malcolm G Common Stock
Nov 30, 2022 Buy 1 250 Witter Malcolm G Common Stock
Nov 30, 2022 Buy 1 250 Scott John K Jr. Common Stock
Nov 30, 2022 Buy 1 250 Cappello Alexander L Common Stock
Nov 30, 2022 Buy 1 250 Bhalla Amit Common Stock
Nov 29, 2022 Buy 30 000 Wilson Joshua M. Common Stock
Oct 31, 2022 Buy 2 500 Witter Malcolm G Common Stock
Oct 31, 2022 Buy 2 500 Scott John K Jr. Common Stock
Oct 31, 2022 Buy 2 500 Cappello Alexander L Common Stock
Oct 31, 2022 Buy 2 500 Bhalla Amit Common Stock
Sep 30, 2022 Buy 0 Wilson Joshua M.
Sep 30, 2022 Buy 0 Wilson Joshua M.
Sep 30, 2022 Buy 2 500 Witter Malcolm G Common Stock
Sep 30, 2022 Buy 2 500 Cappello Alexander L Common Stock
Sep 30, 2022 Buy 2 500 Scott John K Jr. Common Stock
Sep 30, 2022 Buy 2 500 Bhalla Amit Common Stock
Aug 31, 2022 Buy 2 500 Cappello Alexander L Common Stock
Aug 31, 2022 Buy 2 500 Bhalla Amit Common Stock
Aug 30, 2022 Buy 2 500 Witter Malcolm G Common Stock
Aug 30, 2022 Buy 115 Witter Malcolm G Series I Convertible Preferred Stock
Aug 30, 2022 Buy 115 Witter Malcolm G Warrant to Purchase Common Stock
Aug 30, 2022 Buy 115 Witter Malcolm G Warrant to Purchase Common Stock
Aug 30, 2022 Buy 2 500 Scott John K Jr. Common Stock
Aug 30, 2022 Buy 2 400 Scott John K Jr. Series I Convertible Preferred Stock
Aug 30, 2022 Buy 2 400 Scott John K Jr. Series I Convertible Preferred Stock
Aug 30, 2022 Buy 2 400 Scott John K Jr. Warrant to Purchase Common Stock
Aug 30, 2022 Sell 1 740 Scott John K Jr. Series F Redeemable Convertible Preferred Stock
Aug 30, 2022 Sell 1 740 Scott John K Jr. Series F Redeemable Convertible Preferred Stock
Jul 31, 2022 Buy 2 500 Witter Malcolm G Common Stock
Jul 31, 2022 Buy 2 500 Scott John K Jr. Common Stock
Jul 31, 2022 Buy 2 500 Cappello Alexander L Common Stock
Jul 31, 2022 Buy 2 500 Bhalla Amit Common Stock
Jun 30, 2022 Buy 2 500 Witter Malcolm G Common Stock
Jun 30, 2022 Buy 2 500 Scott John K Jr. Common Stock
Jun 30, 2022 Buy 2 500 Cappello Alexander L Common Stock
Jun 30, 2022 Buy 2 500 Bhalla Amit Common Stock
May 31, 2022 Buy 2 500 Witter Malcolm G Common Stock
May 31, 2022 Buy 2 500 Scott John K Jr. Common Stock
May 31, 2022 Buy 2 500 Cappello Alexander L Common Stock
May 31, 2022 Buy 2 500 Bhalla Amit Common Stock
Apr 30, 2022 Buy 2 500 Witter Malcolm G Common Stock
Apr 30, 2022 Buy 2 500 Cappello Alexander L Common Stock
Apr 30, 2022 Buy 2 500 Bhalla Amit Common Stock
Apr 10, 2022 Buy 2 500 Scott John K Jr. Common Stock
Apr 10, 2022 Buy 3 260 Scott John K Jr. Series G Redeemable Preferred Stock
Apr 10, 2022 Buy 3 260 Scott John K Jr. Series G Redeemable Preferred Stock
Apr 10, 2022 Buy 1 740 Scott John K Jr. Series F Redeemable Convertible Preferred Stock
Apr 10, 2022 Sell 50 000 Scott John K Jr. Series E Redeemable Convertible Preferred Stock
Mar 31, 2022 Buy 2 500 Witter Malcolm G Common Stock
Mar 31, 2022 Buy 2 500 Scott John K Jr. Common Stock
Mar 31, 2022 Buy 2 500 Cappello Alexander L Common Stock
Mar 31, 2022 Buy 2 500 Bhalla Amit Common Stock
Feb 28, 2022 Buy 2 500 Witter Malcolm G Common Stock
Feb 28, 2022 Buy 2 500 Scott John K Jr. Common Stock
Feb 28, 2022 Buy 2 500 Cappello Alexander L Common Stock
Feb 28, 2022 Buy 2 500 Bhalla Amit Common Stock
Jan 31, 2022 Buy 2 500 Witter Malcolm G Common Stock
Jan 31, 2022 Buy 2 500 Scott John K Jr. Common Stock
Jan 31, 2022 Buy 2 500 Cappello Alexander L Common Stock
Jan 31, 2022 Buy 2 500 Bhalla Amit Common Stock
Jan 14, 2022 Buy 7 728 Rosol Michael Stanley Common Stock
Dec 31, 2021 Buy 2 500 Witter Malcolm G Common Stock
Dec 31, 2021 Buy 2 500 Scott John K Jr. Common Stock
Dec 31, 2021 Buy 2 500 Cappello Alexander L Common Stock
Dec 31, 2021 Buy 2 500 Bhalla Amit Common Stock
Dec 27, 2021 Buy 100 000 Rosol Michael Stanley Stock Option
Dec 27, 2021 Buy 100 000 Rosol Michael Stanley Stock Option
Nov 30, 2021 Buy 1 250 Witter Malcolm G Common Stock
Nov 30, 2021 Buy 1 250 Winkler Agnieszka Common Stock
Nov 30, 2021 Buy 1 250 Scott John K Jr. Common Stock
Nov 30, 2021 Buy 1 250 Farb Thomas F Common Stock
Nov 30, 2021 Buy 1 250 Cappello Alexander L Common Stock
Nov 30, 2021 Buy 1 250 Bhalla Amit Common Stock
Nov 15, 2021 Buy 2 886 Witter Malcolm G Common Stock
Nov 15, 2021 Buy 30 000 Witter Malcolm G Common Stock
Nov 15, 2021 Buy 2 350 Winkler Agnieszka Common Stock
Nov 15, 2021 Buy 30 000 Winkler Agnieszka Common Stock
Nov 15, 2021 Buy 2 483 Scott John K Jr. Common Stock
Nov 15, 2021 Buy 30 000 Scott John K Jr. Common Stock
Nov 15, 2021 Buy 2 175 Farb Thomas F Common Stock
Nov 15, 2021 Buy 30 000 Farb Thomas F Common Stock
Nov 15, 2021 Buy 3 965 Cappello Alexander L Common Stock
Nov 15, 2021 Buy 30 000 Cappello Alexander L Common Stock
INSIDER POWER
78.649
Last 100 transactions
Buy: 26 134 406 | Sell: 71 109 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 78.649.

In total, the insiders bought 26 134 406 and sold 71 109 NAVB shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Navidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission c... NAVB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT